US Insurer Spending on Ivermectin Prescriptions for COVID-19.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 35024763.
- Also identified by DOI 10.1001/jama.2021.24352 and PMC identifier 8759024.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study examines insurer coverage of ivermectin prescriptions for COVID-19 in the US.
Medical subject headings
- Antiparasitic Agents
- Health Expenditures
- Insurance Carriers
- Ivermectin
- Off-Label Use
- COVID-19 Drug Treatment